Fortrea Holdings
FTRE
20.56
-0.22
-1.06%
Fortrea Holdings
US · FTRE
#2796 by market cap
Listed 2023
20.56
-0.22
-1.06%
Live - 5344 symbols - heartbeat 500s ago
· 2026-10-08 04:52
Pre-market
20.93
+1.81%
After-hours
20.56
0.00%
- Market cap
- 1.96B
- P/E (TTM)i
- -24.77
- P/Bi
- 3.73
- EPSi
- -10.81
- Div yieldi
- 0.00%
- 52W posi
- 80%
Reader sentiment
Are you bullish or bearish on FTRE?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
TD Cowen Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Maintains Target Price $23Market Newswire · 2026/8/4
-
Rating change
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Fortrea Holdings Inc. (FTRE) and UniQure (QURE)TipRanks · 2026/7/30
-
Rating change
A Quick Look at Today's Ratings for Fortrea Holdings(FTRE.US), With a Forecast Between $22 to $26Market Newswire · 2026/7/31
-
UBS Initiates Fortrea Holdings(FTRE.US) With Hold Rating, Announces Target Price $22Market Newswire · 2026/9/30
-
Rating change
TD Cowen Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Raises Target Price to $23Market Newswire · 2026/8/4
-
Rating change
Analysts' Top Healthcare Picks: Revolution Medicines (RVMD), Fortrea Holdings Inc. (FTRE)TipRanks · 2026/9/3
-
Rating change
Analysts Are Bullish on These Healthcare Stocks: Stoke Therapeutics (STOK), Fortrea Holdings Inc. (FTRE)TipRanks · 2026/8/4
-
Rating change
Truist Financial Remains a Buy on Fortrea Holdings Inc. (FTRE)TipRanks · 2026/7/30
-
Rating change
Barclays Keeps Their Hold Rating on Fortrea Holdings Inc. (FTRE)TipRanks · 2026/7/30
-
Barclays Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Maintains Target Price $22Market Newswire · 2026/9/3
-
Rating change
Citi Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Announces Target Price $22Market Newswire · 2026/7/31
-
Rating change
William Blair Maintains Fortrea Holdings(FTRE.US) With Hold RatingMarket Newswire · 2026/9/10
-
UBS Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Maintains Target Price $22Market Newswire · 2026/10/3
-
Rating change
Analysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC), Alnylam Pharma (ALNY) and Fortrea Holdings Inc. (FTRE)TipRanks · 2026/7/31
-
Truist Financial Maintains Fortrea Holdings(FTRE.US) With Buy RatingMarket Newswire · 2026/9/3
-
Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Immunome (IMNM)TipRanks · 2026/9/10
-
Rating change
Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE), AgomAb Therapeutics NV ADR (AGMB) and Sana Biotechnology (SANA)TipRanks · 2026/8/17
-
Rating change
Analysts Have Conflicting Sentiments on These Healthcare Companies: Fortrea Holdings Inc. (FTRE), Medtronic (MDT) and Immunic (IMUX)TipRanks · 2026/9/2
-
Rating change
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), Alpha Tau (DRTS) and Fortrea Holdings Inc. (FTRE)TipRanks · 2026/9/3
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 04:52:21 · For reference only, not investment advice and not tailored to your situation.